Business Description
Eikon Therapeutics is a US-based clinical-stage drug development company founded in 2019 and headquartered in Millbrae, California. The company uses a proprietary technology platform that can observe and measure how proteins interact inside living cells, giving researchers an unusually detailed view of disease biology. This capability drives its pipeline of cancer treatments, which targets a range of tumor types including ovarian, breast, prostate, pancreatic, and brain cancers, as well as tumors with specific genetic profiles that make them vulnerable to particular drug mechanisms.
